智翔金泰：自愿披露关于GR2301注射液获得药物临床试验批准通知书的公告

Core Points - The company Zhixiang Jintai announced that it has received approval from the National Medical Products Administration for the clinical trial of its product GR2301 injection [2] Group 1 - The clinical trial application for GR2301 injection has been approved [2]